Drug
Tapinarof 1
Tapinarof 1: highest development phase Phase 3, developed by Teva. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Teva
Trials
| Drug | Phase | Indication |
|---|---|---|
| Tapinarof Cream 1% NCT06742957 | Phase 3 | Plaque Type Psorisis |
Latest
No recent events.
Follow Tapinarof 1 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.